Evidence map›Paper›PMID 35587499›Full record

ArticlePloS one2022

Impact and benefit-cost ratio of a program for the management of latent tuberculosis infection among refugees in a region of Canada.

Jacques Pépin, France Desjardins, Alex Carignan, Michel Lambert, Isabelle Vaillancourt, Christiane Labrie, Dominique Mercier, Rachel Bourque, Louiselle LeBlanc

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Treatment of tuberculosis infection among immigrants in southern New Brunswick, Canada: A cross-sectional study.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2025
    Article
  2. Enhanced screening for tuberculosis infection among immigrants in southern New Brunswick: A cross-sectional pilot study.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jacques PépinDepartment of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Québec, Canada.ORCID 0000-0002-1074-3655
France DesjardinsClinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada.
Alex CarignanDepartment of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Michel LambertClinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada.
Isabelle VaillancourtClinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada.
Christiane LabrieClinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada.
Dominique MercierClinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada.
Rachel BourqueClinique des Réfugiés, Centre Local de Services Communautaires, Sherbrooke, Québec, Canada.
Louiselle LeBlancDepartment of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Université de Sherbrooke · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe identification and treatment of latent tuberculosis infection (LTBI) among immigrants from high-incidence regions who move to low-incidence countries is generally considered an ineffective strategy because only ≈14% of them comply with the multiple steps of the 'cascade of care' and complete treatment. In the Estrie region of Canada, a refugee clinic was opened in 2009. One of its goals is LTBI management.

methodsKey components of this intervention included: close collaboration with community organizations, integration within a comprehensive package of medical care for the whole family, timely delivery following arrival, shorter treatment through preferential use of rifampin, and risk-based selection of patients to be treated. Between 2009-2020, 5131 refugees were evaluated. To determine the efficacy and benefit-cost ratio of this intervention, records of refugees seen in 2010-14 (n = 1906) and 2018-19 (n = 1638) were reviewed. Cases of tuberculosis (TB) among our foreign-born population occurring before (1997-2008) and after (2009-2020) setting up the clinic were identified. All costs associated with TB or LTBI were measured.

resultsOut of 441 patients offered LTBI treatment, 374 (85%) were compliant. Adding other losses, overall compliance was 69%. To prevent one case of TB, 95.1 individuals had to be screened and 11.9 treated, at a cost of $16,056. After discounting, each case of TB averted represented $32,631, for a benefit-cost ratio of 2.03. Among nationals of the 20 countries where refugees came from, incidence of TB decreased from 68.2 (1997-2008) to 26.3 per 100,000 person-years (2009-2020). Incidence among foreign-born persons from all other countries not targeted by the intervention did not change.

conclusionsAmong refugees settling in our region, 69% completed the LTBI cascade of care, leading to a 61% reduction in TB incidence. This intervention was cost-beneficial. Current defeatism towards LTBI management among immigrants and refugees is misguided. Compliance can be enhanced through simple measures.

Indexed as

Latent TuberculosisRefugeesTuberculosisCanadaHumansMass Screening

Identifiers

PMID35587499
PMCPMC9119458
OpenAlexW4280654358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.